<DOC>
	<DOCNO>NCT00120848</DOCNO>
	<brief_summary>Human Papilloma virus ( HPV ) viruses cause common infection skin genitals men woman . Several type HPV infection transmit sexual activity , woman , infect cervix ( part uterus womb ) . This infection often go away , go away ( call persistent infection ) , lead woman long period time cancer cervix . If woman infect HPV , unlikely get cervical cancer . This observer blind follow study study HPV-001 , evaluate ability HPV vaccine prevent HPV infection . The current study invite 1113 subject HPV-001 study receive three dos vaccine/placebo enrol followed-up several additional year see HPV vaccine prevent HPV-16 HPV-18 infection evaluate safety vaccine . Subjects remain study group primary study . No vaccine placebo administer study . The Protocol Posting update order comply FDA Amendment Act , Sep 2007 .</brief_summary>
	<brief_title>Follow-up Study GSK Biologicals ' Human Papilloma Virus ( HPV ) Vaccine Prevent Cervical Infection Young Adults</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Participated study 580299/001 receive three dos vaccine/placebo . Written inform consent obtain subject prior enrollment Decoding subject 's treatment allocation either subject investigator study 580299/001 .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>30 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>HPV vaccine efficacy</keyword>
	<keyword>Prophylaxis HPV 16/18 infection</keyword>
</DOC>